Cargando…
Stem Cell Therapy in Diabetic Polyneuropathy: Recent Advancements and Future Directions
Diabetic polyneuropathy (DPN) is the most frequent, although neglected, complication of long-term diabetes. Nearly 30% of hospitalized and 20% of community-dwelling patients with diabetes suffer from DPN; the incidence rate is approximately 2% annually. To date, there has been no curable therapy for...
Autores principales: | Akter, Shamima, Choubey, Mayank, Mohib, Mohammad Mohabbulla, Arbee, Shahida, Sagor, Md Abu Taher, Mohiuddin, Mohammad Sarif |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954679/ https://www.ncbi.nlm.nih.gov/pubmed/36831798 http://dx.doi.org/10.3390/brainsci13020255 |
Ejemplares similares
-
Adiponectin: A Promising Target for the Treatment of Diabetes and Its Complications
por: Begum, Mahmuda, et al.
Publicado: (2023) -
Recent advances in the management of diabetic distal symmetrical polyneuropathy
por: Tesfaye, Solomon
Publicado: (2011) -
Xanthine Oxidase Inhibitor, Allopurinol, Prevented Oxidative Stress, Fibrosis, and Myocardial Damage in Isoproterenol Induced Aged Rats
por: Sagor, Md. Abu Taher, et al.
Publicado: (2015) -
Anthrax prophylaxis: recent advances and future directions
por: Williamson, E. Diane, et al.
Publicado: (2015) -
Trematode Proteomics: Recent Advances and Future Directions
por: Bennett, Adam P. S., et al.
Publicado: (2021)